Adverum Biotechnologies Inc (ADVM) — Strategic Asset Allocation Index
Adverum Biotechnologies Inc (ADVM) has a Strategic Asset Allocation Index of 66.5% as of September 2023. Strategic assets (PP&E of $68.25 Million plus long-term investments of $-) total $68.25 Million, measured against net assets of $102.71 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Adverum Biotechnologies Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Adverum Biotechnologies Inc Strategic Asset Allocation Index (2014–2022)
This chart shows how Adverum Biotechnologies Inc's Strategic Asset Allocation Index has evolved across 9 annual periods from 2014 to 2022. As of September 2023, the index stands at 66.5%, representing strategic assets of $68.25 Million against net assets of $102.71 Million USD. See financial agility of Adverum Biotechnologies Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Adverum Biotechnologies Inc (2014–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Adverum Biotechnologies Inc from 2014 to 2022, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Adverum Biotechnologies Inc (ADVM) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 62.7% | $113.86 Million | $113.86 Million | $- | $181.52 Million | ▲ +52.3 pp |
| 2021 | 10.5% | $33.06 Million | $33.06 Million | $- | $316.19 Million | ▲ +4.1 pp |
| 2020 | 6.4% | $27.73 Million | $27.73 Million | $- | $434.35 Million | ▼ -7.8 pp |
| 2019 | 14.2% | $24.88 Million | $24.88 Million | $- | $174.96 Million | ▲ +12.4 pp |
| 2018 | 1.8% | $3.59 Million | $3.59 Million | $- | $201.17 Million | ▲ +0.1 pp |
| 2017 | 1.6% | $3.02 Million | $3.02 Million | $- | $184.03 Million | ▼ -0.3 pp |
| 2016 | 1.9% | $4.17 Million | $4.17 Million | $- | $215.60 Million | ▲ +0.7 pp |
| 2015 | 1.3% | $3.19 Million | $3.19 Million | $- | $252.59 Million | ▲ +0.5 pp |
| 2014 | 0.7% | $1.08 Million | $1.08 Million | $- | $149.48 Million | — |